Trevena, Inc. (OTCPK: TRVN)
Health Care · Biotechnology · US
$0.00
-95.83% today · -95.8% 1Y
Trevena, Inc. (OTCPK: TRVN) operates in the Biotechnology industry within the Health Care sector. The company is valued at $479.00 and employs 23 people.
Over the last twelve months the share price has lost 95.8%, trading between 0.00 and 1.50.
Tweenvest scores Trevena, Inc. across four factors: quality 28/100, value 46/100. Its strongest factor is value.
TRVN price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $479.00
- Revenue (TTM)
- $546.00K
- P/E
- —
- EPS
- -42.72
- Dividend yield
- —
- Beta (5Y)
- -1.95
- 52-week high
- $1.50
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 958.79K
- Employees
- 23
- Next earnings
- —
About Trevena, Inc.
Trevena, Inc. is a biopharmaceutical firm dedicated to discovering and commercializing innovative pharmaceutical solutions for individuals suffering from central nervous system disorders. Its pipeline features several promising drug candidates: OLINVYK (Oliceridine) injection: A G protein-biased mu-opioid receptor (MOR) ligand engineered to manage acute pain ranging from moderate to severe. TRV027: Aimed at addressing acute lung injury, which contributes to acute respiratory distress syndrome (ARDS) and abnormal blood clotting in patients with COVID-19. TRV250: A G protein-biased delta-opioid receptor agonist under development for the treatment of acute migraine. TRV734: A small molecule G protein-biased MOR ligand designed for the management of both moderate-to-severe acute and chronic pain. TRV045: An innovative S1P modulator focused on providing relief for chronic pain. The company has also established a partnership with Imperial College London to investigate TRV027's potential in patients afflicted with COVID-19. Trevena, Inc., founded in 2007, operates from its headquarters in Chesterbrook, Pennsylvania.
- ISIN
- US89532E3071
- Founded
- 2007
- Listed since
- Jan 31, 2014
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Rosetta Genomics Ltd.OTCPK: ROSG.Q | $593.00 | $— | — |
| Adynxx, Inc.OTCPK: ADYX | $581.00 | $— | — |
| GlobeImmune, Inc.OTCPK: GBIM | $575.00 | $— | — |
| Mera Pharmaceuticals, Inc.OTCPK: MRPI | $537.00 | $0.00 | -99.00% |
| Biora Therapeutics, Inc.OTCPK: BIOR.Q | $442.00 | $0.00 | — |
| Tengion, Inc.OTCPK: TNGN.Q | $402.00 | $— | — |
| IMAC Holdings, Inc.OTCPK: BACK | $379.00 | $0.00 | -83.33% |
| Predictive Technology Group, Inc.OTCPK: PRED.Q | $317.00 | $0.00 | -99.90% |
Figures last refreshed Oct 18, 2026.